Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial
- PMID: 35312741
- DOI: 10.1039/d2fo90024f
Expression of concern: Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial
Abstract
Expression of concern for 'Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial' by Alireza Mafi et al., Food Funct., 2018, 9, 4763-4770, DOI: https://doi.org/10.1039/C8FO00888D.
Expression of concern for
-
Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial.Food Funct. 2018 Sep 19;9(9):4763-4770. doi: 10.1039/c8fo00888d. Food Funct. 2018. PMID: 30113051 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
